Oric Pharmaceuticals (ORIC) Treasury Shares (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted Treasury Shares of $1.1 million for Q1 2026, up 86.46% on a QoQ basis from $582533.0 in Q4 2025, and up 18.06% year-over-year from $920060.0 in Q1 2025.
Oric Pharmaceuticals (ORIC) Treasury Shares (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' Treasury Shares history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Treasury Shares rose 18.06% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 18.06% YoY) and the FY2025 annual result came in at $582533.0, up 25.95% from the prior year.
- Treasury Shares was $1.1 million for Q1 2026 at Oric Pharmaceuticals, up from $582533.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.1 million in Q1 2026 and bottomed at $191925.0 in Q4 2022.
- A 5-year average of $571258.1 and a median of $485942.0 in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares soared 123.19% — and 2026, when it increased 18.06%.
- Oric Pharmaceuticals' Treasury Shares stood at $191925.0 in 2022, then jumped by 72.27% to $330631.0 in 2023, then surged by 39.89% to $462507.0 in 2024, then grew by 25.95% to $582533.0 in 2025, then surged by 86.46% to $1.1 million in 2026.
- Business Quant data shows ORIC's Treasury Shares at $1.1 million in Q1 2026, $582533.0 in Q4 2025, and $945945.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 582,533.00 |
| Dec 31, 2025 | 582,533.00 |
| Sep 30, 2025 | 945,945.00 |
| Sep 30, 2025 | 945,945.00 |
| Jun 30, 2025 | 923,573.00 |
| Jun 30, 2025 | 923,573.00 |
| Mar 31, 2025 | 920,060.00 |
| Mar 31, 2025 | 920,060.00 |
| Dec 31, 2024 | 462,507.00 |
| Dec 31, 2024 | 462,507.00 |
| Sep 30, 2024 | 726,035.00 |
| Sep 30, 2024 | 726,035.00 |
| Jun 30, 2024 | 698,910.00 |
| Jun 30, 2024 | 698,910.00 |
| Mar 31, 2024 | 695,246.00 |
| Mar 31, 2024 | 695,246.00 |
| Dec 31, 2023 | 330,631.00 |
| Dec 31, 2023 | 330,631.00 |